SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171843-23-000955
Filing Date
2023-02-14
Accepted
2023-02-14 14:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga_021423.htm SC 13G/A 59417
2 EXHIBIT 99.1 exh_991.htm EX-99.1 4453
  Complete submission text file 0001171843-23-000955.txt   65138
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Subject) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-92189 | Film No.: 23627197
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDICENNA THERAPEUTICS INC. 2 BLOOR ST. W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address
Merchant Fahar (Filed by) CIK: 0001845933 (see all company filings)

Type: SC 13G/A